Success Metrics

Clinical Success Rate
60.0%

Based on 6 completed trials

Completion Rate
60%(6/10)
Active Trials
0(0%)
Results Posted
17%(1 trials)
Terminated
4(27%)

Phase Distribution

Ph not_applicable
7
47%
Ph phase_2
2
13%
Ph phase_3
1
7%

Phase Distribution

0

Early Stage

2

Mid Stage

1

Late Stage

Phase Distribution10 total trials
Phase 2Efficacy & side effects
2(20.0%)
Phase 3Large-scale testing
1(10.0%)
N/ANon-phased studies
7(70.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

60.0%

6 of 10 finished

Non-Completion Rate

40.0%

4 ended early

Currently Active

0

trials recruiting

Total Trials

15

all time

Status Distribution
Completed(6)
Terminated(4)
Other(5)

Detailed Status

Completed6
unknown5
Terminated4

Development Timeline

Analytics

Development Status

Total Trials
15
Active
0
Success Rate
60.0%
Most Advanced
Phase 3

Trials by Phase

Phase 22 (20.0%)
Phase 31 (10.0%)
N/A7 (70.0%)

Trials by Status

completed640%
unknown533%
terminated427%

Recent Activity

Clinical Trials (15)

Showing 15 of 15 trials
NCT07015645

Long-Term Outcomes of Hypopituitarism Following Gamma Knife Radiosurgery for Pituitary Adenomas

Completed
NCT07015710

Gamma Knife Radiosurgery on Tectal Plate Gliomas

Completed
NCT02249572Not Applicable

Vestibular Schwannoma - Radiosurgery or Expectation: V-REX.

Completed
NCT04857905Not Applicable

Dose-staged Gamma Knife Radiosurgery Versus Microsurgical Resection

Unknown
NCT02953717Not Applicable

Cognitive Outcome After SRS or WBRT in Patients With Multiple Brain Metastases (CAR-Study B)

Unknown
NCT02296216Not Applicable

Late Effects of Radiosurgery on Acromegaly Study

Completed
NCT01284699Not Applicable

Evaluation of the Safety and Efficacy of Bilateral Subthalamic Nucleus (SNT) Radiosurgery in Idiopathic Severe Parkinson's Disease Fulfilling Inclusion Criteria for STN Deep Brain Stimulation and Presenting With a Contraindication to Intracerebral Electrode Implantation.

Completed
NCT02255929Not Applicable

Gamma Knife Radiosurgery for Treatment of Essential Tremor

Unknown
NCT02953756

Cognitive Outcome After Gamma Knife Radiosurgery in Patients With Brain Metastases (CAR-Study A)

Completed
NCT02005614Not Applicable

A Pilot/Phase II Study of Gamma Knife Radiosurgery for Brain Metastases Using 3Tesla MRI and Rational Dose Selection

Terminated
NCT03439709Phase 3

Multicenter Evaluation of the Effect of Upfront Radiosurgery on Residual Growth Hormone-secreting Pituitary Adenoma

Unknown
NCT01721603Phase 2

Dabrafenib and Trametinib With Radiosurgery in Melanoma Brain Mets

Terminated
NCT03350139

Evaluation of the Predictors of Clinical and Radiological Response to Gamma-Knife Radiosurgery in the Treatment of Intermediate Ventral Nucleus of the Thalamus (VIM) Thalamotomy Tremor.

Unknown
NCT01970644

Neurocognition After Gamma Knife Radiosurgery for Multiple Brian Metastases

Terminated
NCT01011231Phase 2

Study of Gamma-Knife Radiosurgery Using Magnetic Resonance Imaging (MRI) Spectroscopy for Recurrent Glioma

Terminated

All 15 trials loaded

Drug Details

Intervention Type
RADIATION
Total Trials
15